L-(-)-threo-3-Hydroxyaspartic acid

Transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor CAS# 7298-99-9

L-(-)-threo-3-Hydroxyaspartic acid

Catalog No. BCC6565----Order now to get a substantial discount!

Product Name & Size Price Stock
L-(-)-threo-3-Hydroxyaspartic acid: 5mg $127 In Stock
L-(-)-threo-3-Hydroxyaspartic acid: 10mg Please Inquire In Stock
L-(-)-threo-3-Hydroxyaspartic acid: 20mg Please Inquire Please Inquire
L-(-)-threo-3-Hydroxyaspartic acid: 50mg Please Inquire Please Inquire
L-(-)-threo-3-Hydroxyaspartic acid: 100mg Please Inquire Please Inquire
L-(-)-threo-3-Hydroxyaspartic acid: 200mg Please Inquire Please Inquire
L-(-)-threo-3-Hydroxyaspartic acid: 500mg Please Inquire Please Inquire
L-(-)-threo-3-Hydroxyaspartic acid: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of L-(-)-threo-3-Hydroxyaspartic acid

Number of papers citing our products

Chemical structure

L-(-)-threo-3-Hydroxyaspartic acid

3D structure

Chemical Properties of L-(-)-threo-3-Hydroxyaspartic acid

Cas No. 7298-99-9 SDF Download SDF
PubChem ID 443239 Appearance Powder
Formula C4H7NO5 M.Wt 149.1
Type of Compound N/A Storage Desiccate at -20°C
Synonyms L-<em>threo</em>-β-Hydroxyaspartic acid
Solubility Soluble to 100 mM in 1eq. NaOH
Chemical Name (2S,3S)-2-amino-3-hydroxybutanedioic acid
SMILES C(C(C(=O)O)O)(C(=O)O)N
Standard InChIKey YYLQUHNPNCGKJQ-LWMBPPNESA-N
Standard InChI InChI=1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of L-(-)-threo-3-Hydroxyaspartic acid

DescriptionPotent, competitive, transportable EAAT1-4 inhibitor/non-transportable EAAT5 inhibitor. Also available as part of the Excitatory Amino Acid Transporter Inhibitor.

L-(-)-threo-3-Hydroxyaspartic acid Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

L-(-)-threo-3-Hydroxyaspartic acid Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of L-(-)-threo-3-Hydroxyaspartic acid

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 6.7069 mL 33.5345 mL 67.0691 mL 134.1382 mL 167.6727 mL
5 mM 1.3414 mL 6.7069 mL 13.4138 mL 26.8276 mL 33.5345 mL
10 mM 0.6707 mL 3.3535 mL 6.7069 mL 13.4138 mL 16.7673 mL
50 mM 0.1341 mL 0.6707 mL 1.3414 mL 2.6828 mL 3.3535 mL
100 mM 0.0671 mL 0.3353 mL 0.6707 mL 1.3414 mL 1.6767 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on L-(-)-threo-3-Hydroxyaspartic acid

One-Pot Production of L-threo-3-Hydroxyaspartic Acid Using Asparaginase-Deficient Escherichia coli Expressing Asparagine Hydroxylase of Streptomyces coelicolor A3(2).[Pubmed:25795668]

Appl Environ Microbiol. 2015 Jun;81(11):3648-54.

We developed a novel process for efficient synthesis of L-threo-3-hydroxyaspartic acid (L-THA) using microbial hydroxylase and hydrolase. A well-characterized mutant of asparagine hydroxylase (AsnO-D241N) and its homologous enzyme (SCO2693-D246N) were adaptable to the direct hydroxylation of L-aspartic acid; however, the yields were strictly low. Therefore, the highly stable and efficient wild-type asparagine hydroxylases AsnO and SCO2693 were employed to synthesize L-THA. By using these recombinant enzymes, L-THA was obtained by L-asparagine hydroxylation by AsnO followed by amide hydrolysis by asparaginase via 3-hydroxyasparagine. Subsequently, the two-step reaction was adapted to one-pot bioconversion in a test tube. L-THA was obtained in a small amount with a molar yield of 0.076% by using intact Escherichia coli expressing the asnO gene, and thus, two asparaginase-deficient mutants of E. coli were investigated. A remarkably increased L-THA yield of 8.2% was obtained with the asparaginase I-deficient mutant. When the expression level of the asnO gene was enhanced by using the T7 promoter in E. coli instead of the lac promoter, the L-THA yield was significantly increased to 92%. By using a combination of the E. coli asparaginase I-deficient mutant and the T7 expression system, a whole-cell reaction in a jar fermentor was conducted, and consequently, L-THA was successfully obtained from L-asparagine with a maximum yield of 96% in less time than with test tube-scale production. These results indicate that asparagine hydroxylation followed by hydrolysis would be applicable to the efficient production of L-THA.

(2S,3S,4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate.[Pubmed:7901789]

Neuropharmacology. 1993 Sep;32(9):833-7.

The effects of several diastereoisomers of L-2-(carboxycyclopropyl)glycine (CCG) on L-glutamate uptake were compared among three different preparations, glial plasmalemmal vesicles (GPV), synaptosomes and cultured astrocytes from rat hippocampus. The (2S,3S,4R)-isomer (L-CCG-III) inhibited a Na(+)-dependent high-affinity L-glutamate uptake in GPV and synaptosomes in a dose dependent manner at a micromolar range. The potency was quite similar to that of L-threo-beta-hydroxyaspartate in both subcellular fractions and much higher than L-aspartate-beta-hydroxamate, which were known as potent inhibitors of glutamate uptake. The (2S,3R,4S)-isomer (L-CCG-IV) also inhibited the glutamate uptake in GPV and synaptosomes, but it was about 100 times less active than L-CCG-III. The (2S,3S,4S)- and (2S,3R,4R)-isomers (L-CCG-I and L-CCG-II, respectively) hardly showed any inhibitory action on the glutamate uptake. Dixon plot analysis of the initial uptake rate revealed that the inhibition was in a competitive manner and the value of the inhibition constant (Ki) was about 1 microM in both GPV and synaptosomes. L-CCG-III effectively inhibited the glutamate uptake by cultured hippocampal astrocytes as well. These results suggested that L-CCG-III inhibited the glutamate uptake in both neurones and glial cells of the mammalian central nervous system in a similar manner.

Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum.[Pubmed:2856883]

J Neurochem. 1985 Jan;44(1):247-54.

Destruction of the glutamatergic corticostriatal pathway potentiates the neurotoxic action of 1 mumol L-glutamate injected into the rat striatum, whereas the toxic effects of 10 nmol kainate are markedly attenuated. Injection of 170 nmol of the glutamate uptake inhibitor, DL-threo-3-hydroxyaspartate, into the intact striatum also causes neuronal degeneration, which is accompanied by a reduction in markers for cholinergic and GABAergic neurones. Prior removal of the corticostriatal pathway destroys the ability of DL-threo-3-hydroxyaspartate to cause lesions in the striatum. These results indicate that removal, or blockade, of uptake sites for glutamate increase the vulnerability of striatal neurones to the toxic effects of synaptically released glutamate.

Keywords:

L-(-)-threo-3-Hydroxyaspartic acid,7298-99-9,L-<em>threo</em>-β-Hydroxyaspartic acid,Natural Products,Glutamate (EAAT) Transporters, buy L-(-)-threo-3-Hydroxyaspartic acid , L-(-)-threo-3-Hydroxyaspartic acid supplier , purchase L-(-)-threo-3-Hydroxyaspartic acid , L-(-)-threo-3-Hydroxyaspartic acid cost , L-(-)-threo-3-Hydroxyaspartic acid manufacturer , order L-(-)-threo-3-Hydroxyaspartic acid , high purity L-(-)-threo-3-Hydroxyaspartic acid

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: